Journal of Medicinal Chemistry · 2007 · 61 citations · 33 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryLead OptimizationEnzyme InhibitionPeptide Drug DiscoveryPeptidomimetic DesignPotency OptimizationAmino Acid Side Chain ChemistryCulture Medium OptimizationInhibition ConstantsProteasome InhibitorsProteasome System
We have designed and evaluated 45 linear analogues of the natural constrained cyclopeptide TMC-95A. These synthetically less demanding molecules are based on the tripeptide sequence Y-N-W of TMC-95A. Structural variations in the amino acid side chains and termini greatly influenced both the efficiency and selectivity of action on a given type of active site. Inhibition constants were submicromolar (Ki approximately 300 nM) despite the absence of the entropically favorable constrained conformation that is characteristic of TMC-95A and its cyclic analogues. These linear compounds were readily prepared and reasonably stable in culture medium and could be optimized to inhibit one, two, or all three proteasome catalytic sites. Cytotoxicity assays performed on a series of human tumor cell lines identified the most potent inhibitors in cells.
33
M. Groll, Robert Huber, Barbara C. M. Potts · Journal of the American Chemical Society · 2006 · 314 citations
Yutaka Koguchi, Jun Kohno, MAKI NISHIO et al. · The Journal of Antibiotics · 2000 · 275 citations · Full text